From drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’
The recent run of first-quarter earnings results marked a shift for Big Pharmas away from AI hype and toward explaining how the technology is being applied in p...
The recent run of first-quarter earnings results marked a shift for Big Pharmas away from AI hype and toward explaining how the technology is being applied in practice.